AGP Picks
View all

AGP Executive Report

Last update: 9 hours ago

Mpox Alert (Guinea-Bissau): Guinea-Bissau confirmed its first mpox case and activated national response mechanisms under WHO guidance. Health officials say the patient is a 27-year-old woman who sought care on June 24; samples from her skin lesions were tested locally and then confirmed at Institut Pasteur in Dakar. Public Health Response: Authorities have launched contact tracing, reinforced surveillance across the country and at border points, and urged prevention steps like frequent handwashing and avoiding close contact with people with fever or skin rashes. Symptoms & Transmission: Mpox can spread through body fluids, respiratory droplets, and contaminated materials, with common signs including fever, muscle aches, skin lesions, and swollen lymph nodes. Health Context (Region): Separately, WHO warned Sudan’s cholera outbreak could worsen during the rainy season amid conflict and displacement.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

No AGP Wire articles available right now.


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
One Coptic national player in 100 years — Will FIFA finally ask why?

One Coptic national player in 100 years — Will FIFA finally ask why?

China plays "relevant" role in Guinea-Bissau's health sector: minister

China plays "relevant" role in Guinea-Bissau's health sector: minister

Global and Regional Impact of Pelvic Inflammatory Disease in Females Across All Age Groups (1990–2021) with Projections to 2046: Findings from the 2021 Global Burden of Disease Study

Global and Regional Impact of Pelvic Inflammatory Disease in Females Across All Age Groups (1990–2021) with Projections to 2046: Findings from the 2021 Global Burden of Disease Study


fallback image
Feb. 22, 2026

Guinea-Bissau Stops Trump-Backed Hepatitis B Vaccine Study

MENAFN

fallback image
Feb. 22, 2026

Guinea-Bissau Stops US-Funded Hepatitis B Vaccine Trial

MENAFN

fallback image
Feb. 25, 2026

STAND UP FOR SCIENCE: CDC-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU CANCELLED

EIN Presswire

fallback image
Feb. 17, 2026

STAND UP FOR SCIENCE CONDEMNS U.S.-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU

EIN Presswire

fallback image
May 14, 2026

Itafos and Rio Tinto Amend Sulfuric Acid Contract to Further Support American Farming

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: The Bissago People: Masters of Guinea-Bissau’s Archipelago
Play
The Bissago People: Masters of Guinea-Bissau’s Archipelago
YouTube video thumbnail: Bissagos Islands, on the Mysterious Islands of West Africa
Play
Bissagos Islands, on the Mysterious Islands of West Africa
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Hidden Nature in Guinea Bissau
Play
Hidden Nature in Guinea Bissau
YouTube video thumbnail: How the Cunning Rebels of Guinea-Bissau Shocked the World with Their Success
Play
How the Cunning Rebels of Guinea-Bissau Shocked the World with Their Success

Video Title

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.